OmniComm Systems has entered into a five-year, multi-million dollar electronic data capture enterprise agreement with a major west coast biotechnology company.
Subscribe to our email newsletter
The agreement allows the biotech company to take full advantage of OmniComm’s First in Functionality, EDC solution, TrialMaster for up to 10 concurrent trials per year.
The biotech company will strategically utilize OmniComm’s electronic data capture (EDC) application to assist in managing their global clinical trials and clinical related data. The enterprise deal includes complete licensing, services and technical support for these 10 concurrent studies. The agreement also provides for an option to exceed 10 concurrent studies per year for a predetermined ‘per study’ price.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.